Opinion

The latest opinion pieces by industry thought leaders


If you are interested in having your voice heard on PharmaVoice's Opinion page, please read our editorial guidelines and fill out the submission form here.

  • pills rising
    Image attribution tooltip
    Stock via Getty Images
    Image attribution tooltip

    A key to ‘winning’ in today’s market — and other trends pharma leaders are tracking

    Healthcare pros share the market drivers they believe are having the biggest impact on the industry.

    Taren Grom • June 2, 2023
  • Rashmi Gupta Microsoft
    Image attribution tooltip
    Permission granted by Rashmi Gupta Microsoft
    Image attribution tooltip

    The ‘superpowers’ pharma leaders should cultivate

    Executives honored by the Healthcare Businesswomen’s Association share the key traits that help them drive results.

    Taren Grom • May 26, 2023
  • burnout concept
    Image attribution tooltip
    Stock via Getty Images
    Image attribution tooltip

    How biopharma executives fight burnout

    Pharma leaders share what they do to keep their teams from fizzling out.

    Taren Grom • May 19, 2023
  • team work
    Image attribution tooltip
    Stock via Getty Images
    Image attribution tooltip

    What pharma can teach biotech about the life cycle management of a drug

    Global product teams are common in pharma but have yet to gain traction in biotech. Here's why this model can work.

    Dr. Stephen Dale and Kathleen Ford • May 18, 2023
  • magic wand
    Image attribution tooltip
    Stock via Getty Images
    Image attribution tooltip

    Leaders wave a magic wand at pharma’s thorniest issues

    The major challenges pharma leaders would solve with a quick flick of an imaginary wand.

    PharmaVoice staff • March 31, 2023
  • magic wand
    Image attribution tooltip
    Stock via Getty Images
    Image attribution tooltip

    What would you fix with a ‘magic wand?’ Pharma leaders chime in about clinical trials

    How life science execs would transform clinical trials with a little hocus pocus.

    PharmaVoice staff • March 24, 2023
  • financial storm
    Image attribution tooltip
    Stock via Getty Images
    Image attribution tooltip

    How biotechs can weather the market storm

    Execs at JPM sound off on moves companies can make to survive the challenging market conditions.

    Meagan Parrish • Jan. 13, 2023
  • crystal ball 2023
    Image attribution tooltip
    Stock via Getty Images
    Image attribution tooltip

    The 2023 PharmaVoice Crystal Ball: Peering into the future of life sciences

    A preview of the top trends on the minds of industry and market leaders for the new year.

    Taren Grom • Jan. 3, 2023
  • Wow year
    Image attribution tooltip
    Stock via Getty Images
    Image attribution tooltip

    WoW: What a year

    A look back at some of the most inspirational quotes from the Women of the Week podcasts in 2022.

    Taren Grom • Dec. 20, 2022
  • lightbulb breaking
    Image attribution tooltip
    Stock via Getty Images
    Image attribution tooltip

    Healthcare tech’s biggest busts

    The metaverse, blockchain, DCTs and more — here are some of the most recent fails in healthcare tech.

    Taren Grom • Dec. 2, 2022
  • office red
    Image attribution tooltip
    Stock via Getty Images
    Image attribution tooltip

    Hybrid work is here to stay — here’s how leaders should adjust

    Executives across the life sciences share their tips for navigating the new norm of remote work.

    Taren Grom • Nov. 18, 2022
  • washington flag
    Image attribution tooltip
    iStock via Getty Images
    Image attribution tooltip

    Why the IRA will drive up the country’s drug bill — not lower it

    On the surface, the Inflation Reduction Act is designed to lower drug prices, but its impact on innovation incentives could produce a landscape of new medicines that are costlier for patients.

    John LaMattina • Nov. 14, 2022
  • workplace culture
    Image attribution tooltip
    Stock via Getty Images
    Image attribution tooltip

    Pharma execs on creating a better workplace culture

    Top women execs speak to the leadership skills they are embracing as the industry adjusts to a new normal.

    Taren Grom • Oct. 28, 2022
  • Insomnia in healthcare
    Image attribution tooltip
    Stock via Getty Images
    Image attribution tooltip

    What’s keeping pharma leaders up at night

    C-suite execs in the life sciences share their late-night thoughts including innovation, patient access and market factors.

    Taren Grom • Oct. 21, 2022
  • brand
    Image attribution tooltip
    Stock via Getty Images
    Image attribution tooltip

    What’s your leadership brand?

    Pharma industry leaders share their brand personas.

    Taren Grom • Oct. 14, 2022
  • bad boss
    Image attribution tooltip
    Stock via Getty Images
    Image attribution tooltip

    Are you a bad boss?

    Pharma execs share their tips for being a better leader.

    Taren Grom • Oct. 7, 2022
  • Sophia Sharp-Donaldson, executive director, Global Strategic Sourcing and Procurement, Kite Pharma
    Image attribution tooltip

    Sophia Sharp-Donaldson, executive director, Global Strategic Sourcing and Procurement, Kite Pharma and one of this year's HBA Luminary honorees. 

    Image attribution tooltip

    Why 'soft' skills matter in the new era of leadership

    Standout leaders honored by the Healthcare Businesswomen's Association discuss the rising value of the interpersonal approach.

    Taren Grom • May 12, 2022
  • Image attribution tooltip
    Stock via Getty Images
    Image attribution tooltip

    Industry executives on the milestone moments shaping pharma's future

    Scientific, technological, and communication changes that are making a permanent impact on the industry.

    Taren Grom • Feb. 9, 2022
  • computer keyboard test tube
    Image attribution tooltip
    Retrieved from Google image.
    Image attribution tooltip

    Industry executives predict the next 'blue oceans' in pharma

    Where life science leaders see breakthroughs happening in the industry.

    Taren Grom • Feb. 4, 2022
  • Three people are having an in-office meeting
    Image attribution tooltip
    Pekic via Getty Images
    Image attribution tooltip

    Talent acquisition stays top of mind for pharma execs

    From creating flexible work environments to looking outside the industry for new talent, pharma execs are shifting strategies to keep their teams afloat.

    Taren Grom • Feb. 1, 2022
  • Image attribution tooltip
    Ricardo Ceppi via Getty Images
    Image attribution tooltip

    Biopharma's R&D leaders on how technology can accelerate drug development

    How emerging digital tools are providing enhanced clinical insights and improved trial results.

    Taren Grom • Jan. 27, 2022
  • man in suit patient figures magnifying glass
    Image attribution tooltip
    Retrieved from Google image.
    Image attribution tooltip

    Leaders predict improving patient engagement will lead to growth opportunities

    Why patient engagement is key to successful business growth.

    Taren Grom • Jan. 24, 2022
  • man in suit patient figures magnifying glass
    Image attribution tooltip
    Retrieved from Google image.
    Image attribution tooltip

    Pharma execs reveal the industry's most pressing issues

    Several market factors — including COVID — are driving changes and trends in the industry.

    Taren Grom • Jan. 14, 2022
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Speak Out: The Value of Using Neutral Analysis in Life Sciences Disputes

    Imagine that you have multiple published and peer-reviewed clinical trials and time is of the essence to get your vaccine to market. Unfortunately, you are involved in a lawsuit for patent infringement with a competitor. Will you go to trial? What are your odds of prevailing? HAVE THE RIGHT ST...

    Hon. Gregory M. Sleet (Ret.) • Nov. 15, 2021
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Executive Perspective: Data For Better Health Outcomes: A Conversation with Clark Wooten and Anthony Passarelli

    The COVID-19 pandemic has continued to disrupt the healthcare market across all sectors, and the digital health segment is no exception. But in this case, there has been a positive boost. According to Global Market Insights, the digital health market exceeded $141.8 billion in 2020 and is estimat...

    Clark Wooten • Nov. 15, 2021